Janice Evans

Janice Evans has extensive experience in regulatory affairs and product development within the pharmaceutical industry. Starting at Trega Biosciences in 1993, Janice transitioned to Ancile Pharmaceuticals in 1998, continuing as a regulatory affairs professional until 2002. Janice then served as Director of Drug Regulatory Affairs at Novartis from 2011 to 2014, before moving to Biogen Idec where regulatory affairs expertise was further developed until 2011. Janice briefly worked at La Jolla Pharmaceutical Company in early 2003, followed by a position at Eli Lilly and Company since September 2014 as a Senior Advisor in Regulatory.